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Abstract
As a result of increasing life expectancies, continuing physical careers, lifestyles into later life and rising obesity
levels, the number of younger patients presenting with osteoarthritis (OA) of the knee is increasing. When
conservative management options have been exhausted, the challenge for the orthopedic surgeon is to offer a
procedure that will relieve symptoms and allow a return to a high level of function but not compromise future
surgery that may be required as disease progresses or prostheses fail and require revision. We discuss the options
available to this group of patients and the relative benefits and potential negative points of each. Total knee
replacement (TKR) in the young patient is associated with high risk of early failure and the need for future revision
surgery. After TKR, most surgeons advise limitation of sporting activities. If osteoarthritis is limited to only one
compartment in the knee there may be surgical options other than TKR. Osteotomy above or below the knee may
be considered and works by redirecting the load passing through the joint into the relatively unaffected
compartment. A unicompartmental knee replacement (UKR) or patella-femoral joint (PFJ) replacement only replaces
the articular surfaces in the affected compartment, leaving the unaffected compartments untouched with better
preservation of the soft tissues. Which of these options is best for a particular patient depends upon the patient’s
symptoms, precise pathology, lifestyle, and expectations.
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Background
The number of young patients seeking medical consulta-
tion for symptoms relating to osteoarthritis (OA) of the
knee is increasing [1]. This is thought to be due to a com-
bination of factors [2]. Longer life expectancy also means
that the proportion of the population continuing physi-
cally demanding careers and sporting lifestyles into their
fifth, sixth, and even seventh decades is increasing [3]. In
addition to these risks, there are rising levels of obesity
and there is clear evidence that the risk of OA is increased
with obesity [4]. Allied to the increasing rates of OA are
patient expectations that a return to previous levels of
activity should be possible following injury or trauma.
Osteoarthritis is a dynamic and metabolically active
disease that involves all tissue components of the joint:
bone, cartilage, synovium, muscle, and ligament. The
key pathological features are of articular cartilage soften-
ing, fibrillation, and then ulceration leading to sclerosis
and eburnation of subchondral bone. Articular cartilage
degradation leads to release of inflammatory mediators
and further joint damage due to this inflammatory com-
ponent, thus the frequent reference to ‘degenerative
arthritis’ is incorrect. Subchondral cyst and osteophyte
formation are later features [5].
Patients with OA of the knee present with symptoms
that include joint pain, swelling, stiffness, crepitus, loss of
function, and reduced quality of life [6]. The initial man-
agement of OA of the knee should be non-operative, how-
ever, these measures often provide only limited and
temporary benefit. Not until these options have been
exhausted should surgical options be explored. Non-
operative strategies may include patient education, exer-
cise, weight loss, bracing, analgesia, non-steroidal anti-
inflammatory drugs (NSAIDs) and possibly intra-articular
(IA) injections. Although many of these treatment meth-
ods are employed the evidence for their benefit is mixed.
Meta-analyses have shown the benefit of muscle
strengthening and aerobic exercise in the management
of OA [7,8] but have highlighted the importance of
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patient compliance. The medical benefits of weight loss for
the obese patient are clear. While it seems logical that
weight loss should also relieve the pain associated with
OA the evidence that weight loss can delay or even reverse
symptoms associated with OA of the knee remains mixed
[9]. There are studies that have shown bracing to be effec-
tive [10]. Bracing aims to reduce the biomechanical load
in the affected compartment of the knee, or improve
symptoms by reducing perceived instability. Although
potentially effective, bracing is poorly tolerated by patients
due to discomfort or skin complications, such as blistering,
and there is evidence that compliance with long-term bra-
cing for orthopedic conditions is poor.
Analgesic regimes have been proven to effectively
improve the pain associated with OA. Paracetamol is
effective in reducing the pain associated with OA of the
knee [11] but less so than NSAIDs. Systemic non-steroidal
anti-inflammatory drugs are however associated with an
increased risk of side effects such as gastrointestinal
disturbance.
Intra-articular corticosteroids are widely used to manage
the symptoms of osteoarthritic joints. Several studies and
a Cochrane Review have shown the treatment to be bene-
ficial versus placebo in the knee, but that there is little
evidence to show that this benefit lasts beyond 4 weeks
[12,13]. The 2009 Cochrane review [14] analyzed the
evidence for hyaluronan (HA) and hylan derivatives for
viscosupplementation of the knee. The authors concluded
that these products were comparable in efficacy to sys-
temic forms of active intervention but with more local
reactions and fewer systemic adverse events. The HA pro-
ducts have a more prolonged effect than IA corticoster-
oids. The numerous different HA preparations and
administration regimes make a comparison of cost with
corticosteroid difficult, but the raw cost of the HA is sig-
nificantly more expensive than corticosteroid. Infection
following joint injection is a rare but recognized complica-
tion and there is evidence of a higher risk of joint infection
following TKR in patients who have had IA corticosteroid
treatment. This makes some surgeons wary of offering IA
injections to patients who may be a candidate for future
joint replacement surgery.
Older patients with OA of the knee are successfully
managed with TKR. These have been implanted in one
form or another for over 50 years [15]. Over time both
prostheses and surgical techniques have evolved [16] such
that 15-year survival rates of up to 98% have been reported
in older populations [17]. For young people who may have
a long life expectancy the concern is that the longevity of
the prosthesis does not match that of the patient and com-
plex revision surgery will be inevitable. The longer life
expectancy of younger patients may be compounded by
higher demand resulting in lower implant survival rates.
Julin et al. [18] reported on the survival rates of TKR
between different age groups from the Finnish Arthro-
plasty Register. Follow-up of 32,019 patients showed that
5-year survival rates were 92% and 95% in patients aged ≤
55 and 56 to 65 years, respectively, compared to 97% in
patients who were > 65 years of age (P < 0.001). These dif-
ferences remained statistically different once differences in
implant and fixation type, sex, and diagnosis were adjusted
for. W-Dahl et al. [19] similarly interrogated the Swedish
Register and found a 10-year cumulative revision rate for
patients younger than 55 years of age of 9%. Odland et al.
[20] report 10-year outcomes from a cohort of 59 active
patients (67 knees) of 55 years or younger. A total of 65%
of patients were still performing moderate labor or sport
activities but 16% had undergone revision for wear and/or
osteolysis.
In addition to the issues of implant survival and com-
plexity of future revision surgery, function after TKR
may be a concern for younger and more active patients.
Most surgeons advise against high-impact activities fol-
lowing TKR, which precludes patients from participating
in a wide range of sports. The list of activities ‘not
recommended’ by surgeons after TKR according to
Knee Society surveys in 1999 and 2005 is decreasing
[21] and there is a paucity of evidence to guide patient
advice about sporting activities after this procedure.
There are small-scale series published of patients return-
ing to high-level tennis [22] and golf [23] but these are
in very select patient groups. The principle behind the
advice given to patients to avoid high-impact activities is
that implant wear is related to joint use not duration of
implantation [24].
Regardless of etiology the aims of surgical treatment
for early OA remain the same: to provide pain relief and
enable a return to a high level of function. Additionally,
when considering surgical treatment options the ability
to perform further surgery if disease progresses or
implants fail should be taken into account.
We will discuss the surgical options available to treat
OA of the knee in young adults. Defining ‘young’ in this
context is not simple and will clearly depend on both
the patient’s chronological and biological age, however,
for the purposes of this discussion we consider patients
less than 55 years of age.
Historically, other than TKR the main surgical
options for these patients were considered to be
osteotomy or unicompartmental tibio-femoral knee
replacement (UKR). However, advances in arthroscopic
techniques and biologic treatments have opened up
other potential avenues, as have patella-femoral joint
(PFJ) replacements. We will discuss these treatments
separately and consider the relative benefits and poten-
tial risks of each.
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Discussion
Osteotomy
An osteotomy is a surgical procedure to cut a bone. The
cut bone from the osteotomy is then removed or fixed
into a different position. In the normal knee, loads that are
over twice body weight are imposed on the tibio-femoral
joint during walking. This rises to over five times body
weight in activities such as descending stairs. In patients
with neutral alignment, on standing the mechanical axis of
the lower limbs passes just medial to the anatomical cen-
ter of the knees and during single-leg stance up to 75% of
the knee joint’s load passes through the medial tibial pla-
teau [25]. This load is increased further in patients with
varus alignment (bow leggedness). The most common pat-
tern of symptomatic OA within the knee is articular carti-
lage degeneration predominantly in the medial
compartment. This results in a varus deformity further
increasing load transmission through the already degener-
ate compartment. A high tibial osteotomy (HTO) aims to
redirect the mechanical axis in order to ‘offload’ the med-
ial compartment and transfer more of the load through
the relatively preserved articular cartilage in the lateral
compartment. This has been shown to reduce pain and
slow disease progression [26]. Coventry [27] in the 1960s
recommended a postoperative correction to 10° to 13° of
valgus. Fujisawa et al. describe the degree of correction
differently and have suggested that best results from HTO
are obtained when the mechanical axis line passes through
a point 30% to 40% across the lateral tibial plateau, with
the inner edge marking 0% and the outer edge 100% of
the plateau [28].
Osteotomies around the knee have been performed
since the beginning of the 20th century. There are many
different techniques for performing the osteotomy, aug-
menting, and then fixing the bone. The osteotomy may
be wedge or dome shaped, and if a wedge, either an
opening or closing wedge. In our experience a dome-
shaped osteotomy is rarely performed today and is largely
of historic interest. In the 1970s, Coventry and Insall
popularized an HTO procedure similar to that widely
performed today [27,29,30].
Under radiographic control, a closing-wedge HTO
makes two bone cuts such that a wedge of bone is taken
from the lateral side of the proximal tibia. The potential
drawbacks to this technique are that it involves dissection
of the tibialis anterior, it may necessitate an osteotomy of
the fibula or disruption of the proximal tibio-fibula joint
both of which are associated with a risk of damage to the
common peroneal nerve. This technique also requires care-
ful preoperative planning to ensure a proper correction.
Some surgeons prefer a medial sided approach and an
opening-wedge osteotomy. With this technique the osteot-
omy may be gradually opened until the desired correction
is achieved and the resulting wedge is held open the precise
amount, typically with a plate and screws. The wedge-
shaped defect may be left to fill naturally, bone grafted
with the patient’s own bone, or filled with a synthetic bone
graft substitute, such as tricalcium phosphate. There are no
significant differences in the outcomes of a closing versus
opening wedge osteotomy in comparative studies [31,32].
Recent developments allow the use of ‘computer naviga-
tion’ to accurately perform the desired correction, however,
to date there is no evidence that this technique is asso-
ciated with an improved outcome compared with tradi-
tional techniques for determining the correction. The
cancellous bone in the proximal tibia heals quickly and
patients are often able to weight bear immediately after
surgery. We are aware that some surgeons routinely par-
tially weight bear patients for 6 weeks following HTO,
allowing full-weight bearing when radiographic evidence of
bony union is seen. Some surgeons routinely remove the
plate and screws once bony healing has been achieved in
anticipation of further surgery. There are limits to the
extent of mechanical axis correction achievable with
internally fixed osteotomies. Significant deformities or
patients who require additional bone lengthening may be
best managed with gradual correction using an external
fixator according to Ilizarov’s techniques of distraction
osteogenesis [33,34].
The principal advantages of the HTO over alternative
operations are the ability to correct deformity and the
preservation of bone stock, which allows any future
arthroplasty to be performed with relative simplicity.
After osteotomy, patients are not usually requested to
restrict their activities and the level of function is lim-
ited only by symptoms. Therefore an HTO is thought to
be a good option for heavy and high-demand patients.
Evidence suggests that the outcome of osteotomy is
more predictable in males versus females [35].
As load is being transferred from one side of the knee
to the other, HTO is relatively contraindicated in patients
with OA affecting more than one compartment of the
knee or pathology in the compartment into which load is
transferred (for example, a significant meniscal tear). The
osteotomy may increase forces at the patella-femoral
joint and therefore is contraindicated in patients with sig-
nificant patella-femoral symptoms or patella alta or baja.
Before HTO patients must be counseled that they may
notice a visible change in the alignment of their leg and a
mild leg length discrepancy.
Isolated lateral compartment OA is seen less frequently.
This may be managed with an osteotomy transferring the
mechanical axis to the medial compartment according to
the same biomechanical principles employed in an HTO
for medial disease. Many patients with isolated lateral
compartment OA have a pre-existing valgus (knocked
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knee) deformity that is typically secondary to an underde-
veloped lateral femoral condyle. This means that correct-
ing the deformity on the tibial side of the joint will lead to
an oblique joint line, which is considered detrimental to
the long-term function of the joint. For this reason the
deformity is classically corrected by a distal femoral osteot-
omy (DFO). The literature suggests that the outcome of
DFO is less predictable than that of HTO.
High tibial osteotomy should not be considered defini-
tive treatment for an osteoarthritic knee but rather as a
means of providing sufficient symptomatic relied to
delay the need joint replacement. Survivorship, defined
as time to arthroplasty, is reported variably in the litera-
ture but may be as high as 98% at 10 years and 70% at
20 years [36-38]. However, reviewing the literature as a
whole the average survivorship is approximately 60% to
70% at 10 years.
A concern of HTO is its potential affect on future TKR.
Some surgeons routinely remove metalwork from the
knee in anticipation of future arthroplasty but there is lit-
tle evidence to support this. Incisions must be carefully
planned to avoid future wound healing problems and
limitations to exposure. The literature suggests that the
results of TKR after HTO are not significantly different
from those of TKR in an unoperated knee [39]. Our
experience is that while the results of TKR after HTO are
good this is more technically demanding than a TKR in a
‘virgin’ knee.
Unicompartment knee replacement
Gunston and Marmor introduced unicompartment knee
replacements independently in the 1970s. Early designs
consisted of a stainless steel runner and a track of high
molecular weight polyethylene that was used in either a
unicompartmental or bicompartmental joint replacement
[40]. Early outcomes were disappointing, and conse-
quently many surgeons chose to treat their patients with
single compartment OA with a TKR or HTO. In 1988,
Marmor published results demonstrating 21 out of 97
cases had failed at 10 to 13-year follow-up [41]. More
recently there has been resurgence in UKR [42] that may
have been driven by several publications showing much
improved survival and satisfaction rates [43,44].
UKR has theoretical benefits over TKR, which include:
preservation of bone stock and soft tissues, preservation
of a more natural gait pattern and kinematics, improved
range of motion, reduced operative time, and reduced
incision size.
Schneider et al. [45] specifically assessed the outcome of
UKR in the younger patient. A total of 28 patients under
60 years (average age 52 years) were followed up between
2 and 6 years. Pain relief and function were described as
good or excellent in 90% of cases. Of note, activity levels
as described by Tegner and Lysholm improved slightly
from 2.3 points preoperatively to 2.7 points postoperati-
vely.
There have been a few prospective studies randomizing
patients to HTO or UKR and evaluating functional out-
comes. Borjesson et al. [46] used the British Orthopaedic
Association score, gait analysis, range of movement and
patient satisfaction measures to compare patients aged 55
to 70 with moderate medial knee arthritis randomized to
either HTO or UKR. No differences were noted between
the groups other than at 3 months after surgery when
there was a significant difference in the time-distance vari-
able of gait in favor of UKR. This became insignificant at
1-year and 5-year follow-up.
Ivarsson and Gillquist [47] evaluated the rehabilitation
programs of ten HTO and ten UKR patients with an
average age of 63 years. Gait analysis was performed
alongside Lysholm knee function scoring and measures
of muscle strength. Assessment at 6 months revealed
greater strength in the UKR group compared to the HTO
group but this had equalized by 12 months. Lysholm
function scores were greater in the UKR group but not
with statistic significance. Gait analysis demonstrated
increased maximal gait velocity and duration of single-leg
support in the UKR group postoperatively versus preo-
peratively. No such difference was observed in the HTO
cohort.
As with HTO, patients have to be carefully selected
for UKR. The procedure is contraindicated in patients
with an inflammatory arthropathy, the disease should be
confined to one side of the joint, however, in some pub-
lishes series asymptomatic patellofemoral OA is not
seen as a contraindication to unicompartmental tibio-
femoral replacement. The knee must flex beyond 120°
(to allow preparation of the femoral bone surface and
insertion of the components), any varus or valgus defor-
mity must be passively correctable and less than 15°,
and there must be less than 5° of fixed flexion defor-
mity. For some fixed-bearing tibial component designs,
a weight limit of 114 kg has been set. Traditionally, an
anterior cruciate ligament (ACL) deficient knee was
considered a contraindication to UKR, but this has not
been borne out in the literature for fixed bearing joint
replacements [48].
The author’s experience of revising UKR to TKR is
that it is typically a straightforward procedure similar to
a primary TKR. However, a failed UKR may be asso-
ciated with significant bone loss making revision a more
complicated undertaking. Specific revision implants may
be required with metal or bone augmentation to areas
of bone loss. The published literature suggests that revi-
sion of a failed UKR to a second UKR is associated with
a threefold risk of further revision compared to patients
revised to a TKR [49] and the authors would not advo-
cate this treatment. Reports of the outcomes of UKR
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revised to TKR are variable but typically similar to those
of revision TKR, which are inferior to primary TKR [50].
Patellofemoral joint replacement
Osteoarthritis of the knee confined to the PFJ in isolation
is seen in approximately 10% of patients, and most fre-
quently in females. Along with UKR, PFJ replacements
were introduced in the 1970s. Interest in their use has
been renewed recently. We consider this option in patients
with predominant symptoms of PFJ arthritis and radio-
graphic evidence of OA isolated to the PFJ. This procedure
has the same theoretical benefits as any UKR over TKR
including reduced operative time, less invasive surgery,
quicker postoperative rehabilitation and relative ease of
revision. As the cruciate ligaments and femoro-tibial com-
partments are preserved knee kinematics and gait are
better preserved [51]. The Bristol Knee Group [52] per-
formed over 425 PFJ arthroplasties reporting 95.8% 5-year
survivorship and improved function with Oxford knee
scores increasing from 18 to 39 points out of 48. In 3% of
cases maltracking was observed, some of which requiring
distal alignment revision surgery. In all, 7% of cases devel-
oped disease in the medial or lateral tibiofemoral joint
causing recurrent pain. A retrospective review comparing
the outcomes of patients with an average age of 60 years
undergoing PFJ replacement with patients receiving TKR
found similar postoperative Knee Society Clinical Rating
System scores but reduced blood loss and hospital stay in
the PFJ group [53]. The authors concluded that isolate PFJ
arthroplasty yields similar clinical outcomes to TKR but is
a less invasive option for this select subgroup of patients.
We believe that PFJ replacement is a viable option for
patients with symptomatic isolated PFJ OA but we counsel
patients that the long-term outcome of this procedure is
as yet unclear and future revision to a TKR is likely.
Minimally invasive techniques
Arthroscopy
The role of arthroscopy in the treatment of OA is con-
troversial. It is a safe, relatively straightforward treat-
ment and therefore widely used. This use is not
supported in the literature by clear evidence of a signifi-
cant or lasting benefit. In a trial of 180 patients rando-
mized to arthroscopic lavage, debridement, or placebo
[54], no benefit was seen between surgery and placebo
in terms of pain scores or function at 2-year follow-up.
The average patient age was 53 years. Patients with OA
may have associated symptomatic meniscal pathology
but the contribution of this to overall levels of symp-
toms can be difficult to determine. The UK National
Institute of Clinical Excellence (NICE) advise that
arthroscopy, with or without debridement, should only
be offered to patients as part of a treatment for OA if
there is a clear history of ‘locking, not gelling, or giving
way’, or radiographic evidence of loose bodies [55].
Arthroscopy for OA is not an entirely benign procedure
and complications are described including reports of
insufficiency fractures following knee arthroscopy. The
pathological process appears to be subchondral fracture
rather than osteonecrosis in this rare complication [56].
The authors believe that arthroscopy has a very limited
role in the management of the osteoarthritic knee. We
would consider arthroscopy only where there are clear
signs and symptoms of meniscal pathology, a history con-
sistent with true mechanical locking, or symptomatic
loose bodies, superimposed on typical symptoms of OA.
Microfracture
Microfracture is a minimally invasive technique that is
performed arthroscopically. In patients with relatively
small (1 to 2 cm2) and isolated chondral lesions the
exposed subchondral bone is penetrated with an arthro-
scopic drill or awl with the aim of releasing pluripotent
stem cells from the marrow. The hope is that the stem
cells migrate into the resulting fibrin clot with the area
being replaced with fibrous tissues, fibrocartilage, or hya-
line-like cartilage. The technique has been described as
‘quite effective’ in treating non-weight bearing lesions in
patients less than 35 years [57] but has poor outcomes in
the osteoarthritic knee in the older patient [58]. The
author’s opinion is that this technique has little evidence
to support its use in the management of significant OA.
Chondrocyte implantation
Techniques of autologous chondrocyte implantation
(ACI) and its variants, which include matrix-induced
autologous chondrocyte implantation (MACI), are
attracting great interest in the treatment of discrete
chondral lesions. Such lesions usually are traumatic in
origin but may with time lead to more widespread OA.
The evidence for these techniques is mixed. A number
of uncontrolled studies show symptomatic improvement
following these techniques, however three well con-
ducted randomized controlled trials (RCTs) compared
ACI with microfracture and found no clinically signifi-
cant difference beyond short-term follow-up [59-61]. All
groups demonstrated ‘hyaline-like’ articular cartilage at
biopsy. The authors believe that while these techniques
may have a place in the management of isolated articu-
lar cartilage lesions that is yet to be firmly established,
there is no evidence to support their use in more wide-
spread OA of the knee.
Summary
The management of the young patient with an osteoar-
thritic knee remains a significant challenge for the ortho-
pedic surgeon. Multiple non-surgical treatments are
available, but are unlikely to offer a lasting improvement
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in symptoms. We believe that with careful interrogation
of patient’s symptoms and a thorough examination it is
usually possible to identify those osteoarthritic knees
with coexisting pathology amenable to arthroscopic treat-
ment, leading to an improvement in symptoms and delay
of more invasive surgery.
Once these options are exhausted, the main choice is
between HTO, UKR or TKR. While TKR remains an
option that must be considered in the young patient the
reduced longevity and higher expectations in this group
allied to potential bone loss associated with a failed TKR
mean that whenever possible we prefer to consider the
options of HTO or UKR. Which option is most suitable
depends upon patient characteristics and expectations.
In our practice, young, active and heavier males tend to
be offered HTO. In young patients who fall outside this
group our experience is that unicompartmental knee
replacement is a successful procedure and we have had
success revising these implants to TKR.
Autologous chondrocyte implantation and other techni-
ques of ‘biological’ joint replacement are exciting treat-
ment prospects for the future but are not currently
supported by evidence.
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